Literature DB >> 16324890

Development and validation of a sensitive assay of valproic acid in human plasma by high-performance liquid chromatography without prior derivatization.

Hossein Amini1, Mohammad Javan, Abolhassan Ahmadiani.   

Abstract

Sensitive and selective determination of valproic acid in plasma by high-performance liquid chromatography (HPLC) is usually achieved with pre-column derivatization. In the present work, the derivatization is omitted due to using a simple but highly selective plasma extraction procedure and an optimized chromatographic condition. Valproic acid and the internal standard octanoic acid were extracted from plasma samples with n-hexane under acidic condition followed by back-extraction into diluted triethylamine. Chromatography was performed on a CN column (250 x 4.6 mm, 5 microm) under isocratic elution with acetonitrile-40 mM aqueous sodium dihydrogen phosphate (30:70, v/v), pH 3.5. Detection was made at 210 nm and analyses were run at a flow-rate of 1 ml/min. The method was specific and sensitive with a quantification limit of 1.25 microg/ml and a detection limit of 0.1 microg/ml in plasma. The mean absolute recovery for valproic acid using the present plasma extraction procedure was 75.8%. The intra- and inter-day coefficient of variation and percent error values of the assay method were all in acceptable range. Calibration curves were linear (r>0.999) from 1.25 to 320 microg/ml in plasma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16324890     DOI: 10.1016/j.jchromb.2005.11.028

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

1.  Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.

Authors:  Juseop Kang; Yoo-Sin Park; Shin-Hee Kim; Sang-Hyun Kim; Min-Young Jun
Journal:  Korean J Physiol Pharmacol       Date:  2011-04-30       Impact factor: 2.016

2.  The effect of uridine diphosphate glucuronosyltransferase (UGT)1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach.

Authors:  Murali Munisamy; Manjari Tripathi; Madhuri Behari; S Raghavan; D C Jain; Barghavi Ramanujam; Karthik Arumugam; Thiyagu Rajakannan; Surulivel Rajan Mallayasamy; Vivekanandhan Subbiah
Journal:  Mol Diagn Ther       Date:  2013-10       Impact factor: 4.074

3.  Sex related differences on valproic acid pharmacokinetics after oral single dose.

Authors:  Manuel Ibarra; Marta Vázquez; Pietro Fagiolino; Hartmut Derendorf
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-06-20       Impact factor: 2.745

4.  Hyperammonemia associated with valproic acid concentrations.

Authors:  Marta Vázquez; Pietro Fagiolino; Cecilia Maldonado; Ismael Olmos; Manuel Ibarra; Silvana Alvariza; Natalia Guevara; Laura Magallanes; Ivette Olano
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

5.  L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report.

Authors:  Cecilia Maldonado; Natalia Guevara; Alicia Silveira; Pietro Fagiolino; Marta Vázquez
Journal:  J Int Med Res       Date:  2017-04-20       Impact factor: 1.671

6.  Use of TLC-Densitometric Method for Determination of Valproic Acid in Capsules.

Authors:  Wioletta Parys; Alina Pyka-Pająk
Journal:  Molecules       Date:  2022-01-24       Impact factor: 4.411

7.  Determination of valproic acid in human plasma using dispersive liquid-liquid microextraction followed by gas chromatography-flame ionization detection.

Authors:  Rana Fazeli-Bakhtiyari; Vahid Panahi-Azar; Mohammad Hossein Sorouraddin; Abolghasem Jouyban
Journal:  Iran J Basic Med Sci       Date:  2015-10       Impact factor: 2.699

8.  Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia.

Authors:  Cecilia Maldonado; Natalia Guevara; Cecilia Queijo; Raquel González; Pietro Fagiolino; Marta Vázquez
Journal:  Biomed Res Int       Date:  2016-02-21       Impact factor: 3.411

9.  VPA/PLGA microfibers produced by coaxial electrospinning for the treatment of central nervous system injury.

Authors:  K P Reis; L E Sperling; C Teixeira; L Sommer; M Colombo; L S Koester; P Pranke
Journal:  Braz J Med Biol Res       Date:  2020-04-09       Impact factor: 2.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.